Its seems fairly clear that its do or die for MON.The company has been steered into a dicth which just comes down to really really bad management.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025